Chair: Sefi Rosenbluh
Restoring Tumor Suppressor Function in TP53 Y220C–Mutant Cancers (134421)
8:30 AM
Accelerating prediction of tumor vulnerabilities using precision functional genomics (134594)
9:00 AM
Target Validation in Cancer Drug Discovery: Why It Matters (134218)
9:30 AM
Cu-Later AML:Inhibition of Heme Biosynthesis Triggers Cuproptosis in Acute Myeloid Leukaemia (131760)
10:00 AM
Targeting a mito-ER stress-sensing ubiquitin complex collapses organellar stress tolerance to force BCL-2/XL addiction in blood cancers (130254)
10:15 AM
Session Sponsor

CANCER 2026